Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M21 for a violation of the Anti-Doping Rules. During the "championnat d'Auvergne de velo tout-terrain", on June 17, 2012, a sample for doping purposes was taken from the respondent. The sample showed the presence of bendroflumethiazid which is a prohibited substance on the World Anti-Doping Agency (WADA) prohibited list.
History
The respondent used medication for pre menstrual pains (PMS) which contained the prohibited substance.
A therapeutic use exemption (TUE) was refused by the French Anti-Doping Agency. There are alternatives for the medication she uses without the prohibited substance.
Decision
1. A warning is delivered to the respondent.
2. The decision starts on the date of the notification.
3. The decision will be published and sent to the involved parties.
